1 |
World Health Organization, Diabetes, Available from, 2019.
URL
|
2 |
郑义,康凯,王智杰,等. 中枢敏化及其对膝关节骨关节炎临床治疗的影响[J/CD]. 中华老年骨科与康复电子杂志,2020,6(4):243-247.
|
3 |
Miyake H, Kanazawa I, Sugimoto T. Association of bone mineral density, bone turnover markers, and vertebral fractures with All-Cause mortality in type 2 diabetes mellitus [J]. Calcif Tissue Int, 2018, 102(1): 1-13.
|
4 |
Gilbert MP, Pratley RE. The impact of diabetes and diabetes medications on bone health [J]. Endocr Rev, 2015, 36(2): 194-213.
|
5 |
Guo Y, Wang Y, Chen F, et al. Assessment of risk factors for fractures in patients with type 2 diabetes over 60 years old: a Cross-Sectional study from Northeast China [J]. J Diabetes Res, 2020: 1508258.
|
6 |
Stumpf U, Hadji P, Van Den Boom L, et al. Incidence of fractures in patients with type 1 diabetes mellitus-a retrospective study with 4420 patients [J]. Osteoporos Int, 2020, 31(7): 1315-1322.
|
7 |
Ahmed LA, Joakimsen RM, Berntsen GK, et al. Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study [J]. Osteoporos Int, 2006, 17(4): 495-500.
|
8 |
Berry SD, Zullo AR, Lee Y, et al. Fracture risk assessment in long-term care (FRAiL): development and validation of a prediction model [J]. J Gerontol A Biol Sci Med Sci, 2018, 73(6): 763-769.
|
9 |
HF Chen, CA Ho, CY Li. Increased risks of hip fracture in diabetic patients of Taiwan: a population-based study [J]. Diabetes Care, 2008, 31(1): 75-80.
|
10 |
L de II, M van der Klift, CE de Laet,, et al. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam study [J]. Osteoporos Int, 2005, 16(12): 1713-1720.
|
11 |
Dobnig H, Piswanger-Sölkner JC, Roth M, et al. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk [J]. J Clin Endocrinol Metab, 2006, 91(9): 3355-3363.
|
12 |
L Forsen, HE Meyer, K Midthjell, et al. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag health survey [J]. 1999, Diabetologia, 42(8): 920-925.
|
13 |
Y Gerber, Melton LJ 3rd, SM McNallan, et al. Cardiovascular and noncardiovascular disease associations with hip fractures [J]. Am J Med, 2013, 126(2): 19-26.
|
14 |
Hamilton EJ, Davis WA, Bruce DG, et al. Risk and associates of incident hip fracture in type 1 diabetes: The Fremantle Diabetes Study [J]. Diabetes Res Clin Pract, 2017, 134: 153-160.
|
15 |
RQ Ivers, RG Cumming, P Mitchell, et al. Diabetes and risk of fracture: the Blue Mountains eye study [J]. Diabetes Care, 2001, 24(7): 1198-1203.
|
16 |
M Janghorbani, D Feskanich, WC Willett, et al. Prospective study of diabetes and risk of hip fracture: the Nurses’ health study [J]. Diabetes Care, 2006, 29(7): 1573-1578.
|
17 |
Kim SH, Kim YM, Yoo JS, et al. Increased risk of hip fractures in Korean patients with type 2 diabetes: a 6-year nationwide population-based study [J]. J Bone Miner Metab, 2017, 35(6): 623-629.
|
18 |
WP Koh, R Wang, LW Ang, et al. Diabetes and risk of hip fracture in the Singapore Chinese Health Study [J]. Diabetes Care, 2010, 33(8): 1766-1770.
|
19 |
Lee RH, Sloane R, Pieper C, et al. Clinical fractures among older men with diabetes are mediated by diabetic complications [J]. J Clin Endocrinol Metab, 2018, 103(1): 281-287.
|
20 |
WD Leslie, LM Lix, HJ Prior, et al. Biphasic fracture risk in diabetes: a population-based study [J]. Bone, 2007, 40(6): 1595-1601.
URL
|
21 |
WD Leslie, LM Lix, HJ Prior, et al. Biphasic fracturerisk in diabetes: a population-based study [J]. Bone, 2007, 40(6): 1595-1601.
URL
|
22 |
Majumdar SR, Leslie WD, Lix LM, et al. Longer duration of diabetes strongly impacts fracture risk assessment: the Manitoba BMD cohort [J]. J Clin Endocrinol Metab, 2016, 101(11): 4489-4496.
|
23 |
LL Lipscombe, SA Jamal, GL Booth, et al. The risk of hip fractures inolder individuals with diabetes: a population-based study [J]. Diabetes Care, 2007, 30(4): 835-841.
|
24 |
Martinez-Laguna D, Tebe C, Javaid MK, et al. Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study [J]. Osteoporos In, 2015, 26(2): 827-833.
|
25 |
Reyes C, Estrada P, Nogués X, et al. The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study [J]. Osteoporos Int, 2014, 25(6): 1751-1758.
|
26 |
Meyer H, Tverdal A, Falch JA. Risk factors for hip fracture in middle-aged Norwegian women and men [J]. Am J Epidemiol, 1993, 137(11): 1203-1211.
|
27 |
KK Nicodemus, AR Folsom. Type 1 and type 2 diabetes and incident hip fracturesin postmenopausal women [J]. Diabetes Care, 2001, 24(7): 1192-1197.
|
28 |
G Poor, EJ Atkinson, WM O’Fallon, et al. Predictors of hip fracturein elderly men [J]. J Bone Miner Res, 1995, 10(12): 1900-1907.
|
29 |
Schwartz AV, Sellmeyer DE, Ensrud K, et al. Older women with diabetes have an increased risk of fracture: a prospective study [J]. J Clin Endocrinol Metab, 2001, 86(1): 32-38.
|
30 |
Segal E, Raichlin V, Rimbrot S, et al. Hip fractures in the elderly in Israel-possible impact of preventable conditions [J]. Arch Gerontol Geriatr, 2009, 48(2): 182-185.
|
31 |
Strotmeyer ES, Kamineni A, Cauley JA, et al. Potential explanatory factors for higher incident hip fracture risk in olderdiabetic adults [J]. Curr Gerontol Geriatr Res, 2011: 979270.
|
32 |
Wallander M, Axelsson KF, Nilsson AG, et al. Type 2 diabetes and risk of hip fractures and Non-Skeletal fall injuries in the elderly: a study from the fractures and fall injuries in the elderly cohort (FRAILCO) [J]. J Bone Miner Res, 2017, 32(3): 449-460.
|
33 |
Jung JK, Kim HJ, Lee HK, et al. Fracture incidence and risk of osteoporosis in female type 2 diabetic patients in Korea [J]. Diabetes Metab J, 2012, 36(2): 144-150.
|
34 |
Keegan TH, Kelsey JL, Sidney S, et al. Foot problems as risk factors of fractures [J]. Am J Epidemiol, 2002, 155(10): 926-931.
|
35 |
L Oei, MC Zillikens, A Dehghan, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study [J]. Diabetes Care, 2013, 36(6): 1619-1628.
URL
|
36 |
Kaur H, Joshee P, Franquemont S, et al. Bone mineral content and bone density is lower in adolescents with type 1 diabetes: A brief report from the RESISTANT and EMERALD studies [J]. J Diabetes Complications, 2018, 32(10): 931-933.
|
37 |
Shah VN, Harrall KK, Shah CS, et al. Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature [J]. Osteoporosis International, 2017, 28(9): 2601-2610.
|
38 |
Thong EP, Herath M, Weber DR, et al. Fracture risk in young and middle-aged adults with type 1 diabetes mellitus: A systematic review and meta-analysis [J]. Clin Endocrinol (Oxf), 2018, 89(3): 314-323.
|
39 |
Nicodemus KK, Folsom AR. Iowa women's health S.type 1 and type 2 diabetes and incident hip fractures inpostmenopausal women [J]. Diabetes Care, 2001, 24(7): 1192-1197.
|
40 |
Nicodemus KK, Folsom AR. Iowa women's health S.type 1 and type 2 diabetes and incident hip fractures inpostmenopausal women [J]. Diabetes Care, 2001, 24(7): 1192-1197.
|
41 |
Jiajue R, Qi X, Jiang Y, et al. Incident fracture risk in type 2 diabetic postmenopausal women in mainland China: peking vertebral fracture study [J]. Calcif Tissue Int, 2019, 105(5): 466-475.
|
42 |
刘玉章,潘东续,赵晓英,等. 特立帕肽联合双膦酸盐对老年性椎体压缩骨折术后骨质疏松患者PINP和CTX-1的影响[J]. 中华老年骨科与康复电子杂志,2020,6(5):271-278.
|
43 |
张亚玲,王琳,王敬贤,等. 双膦酸盐治疗骨质疏松症与总死亡率相关性的meta分析[J]. 中华老年骨科与康复电子杂志,2020,6(5):304-311.
|
44 |
王建华. 骨质疏松症治疗药物的分类与用药选择[J]. 中华老年骨科与康复电子杂志,2019,5(5):297-300.
|
45 |
李沫,王海旸,王丽娟,等. 老年骨质疏松常用治疗药物的研究现状及展望[J]. 中华老年骨科与康复电子杂志,2019,5(6):365- 369.
|
46 |
刘宇航,张永明,王建华. 唑来磷酸钠联合骨化三醇治疗原发性骨质疏松症的疗效观察[J]. 中华老年骨科与康复电子杂志,2019,5(4):206-210.
|